BOOK
Hypertension and Hypertensive Heart Disease, An Issue of Cardiology Clinics - E-Book
(2010)
Additional Information
Book Details
Abstract
Hypertensive heart disease, the number one cause of death associated with hypertension, refers to coronary artery disease, heart failure, and enlargement of the heart that occurs because of high blood pressure. This issue summarizes the current state-of-the-art in diagnosing, treating, and preventing this potentially fatal disease so that cardiologists can offer the best current treatment to their patients.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Contributors | iii | ||
| Contents | v | ||
| Cardiology Clinics | ix | ||
| Foreword | xi | ||
| Preface Hypertension and Hypertensive Heart Disease | xiii | ||
| Chapter 1. Pathogenesis and Clinical Physiology of Hypertension | 545 | ||
| THE PHYSIOLOGY OF NORMAL BP CONTROL | 545 | ||
| PATHOPHYSIOLOGIC STATES OF CHRONIC BP INCREASE | 550 | ||
| PATHOGENESIS OF PRIMARY HYPERTENSION | 550 | ||
| THE ROLE OF GENES | 550 | ||
| THE ROLE OF ENVIRONMENT | 550 | ||
| THE SNS | 551 | ||
| THE RAAS | 553 | ||
| VASCULAR REMODELING, HYPERTROPHY, AND INCREASED PERIPHERAL RESISTANCE | 553 | ||
| HYPERINSULINEMIA AND INSULIN RESISTANCE | 554 | ||
| THE KIDNEY AND PRIMARY HYPERTENSION | 554 | ||
| A UNIFYING PATHWAY FOR THE DEVELOPMENT OF HYPERTENSION | 554 | ||
| IMPLICATIONS FOR CLINICAL MANAGEMENT OF HYPERTENSION | 556 | ||
| SUMMARY | 556 | ||
| REFERENCES | 556 | ||
| Chapter 2. Prehypertension: An Opportunity for a New Public Health Paradigm | 561 | ||
| CLINICAL EPIDEMIOLOGY OF PREHYPERTENSION | 562 | ||
| CLINICAL EPIDEMIOLOGY AND TREATMENT CONSIDERATIONS IN STAGE 2 PREHYPERTENSION | 564 | ||
| SUMMARY | 567 | ||
| REFERENCES | 567 | ||
| Chapter 3. Principles and Techniques of Blood Pressure Measurement | 571 | ||
| BASIC TECHNIQUES OF BLOOD PRESSURE MEASUREMENT | 571 | ||
| HOW SHOULD DIFFERENT BLOOD PRESSURE MEASUREMENT TECHNIQUES BE USED? | 580 | ||
| SUMMARY | 582 | ||
| REFERENCES | 583 | ||
| Chapter 4. Initial Clinical Encounter with the Patient with Established Hypertension | 587 | ||
| THE INITIAL COMPREHENSIVE EVALUATION | 588 | ||
| BP CLASSIFICATION AND STAGING OF HYPERTENSION | 588 | ||
| INITIAL LABORATORY TESTS | 590 | ||
| ASSESSMENT OF GLOBAL CV RISK | 591 | ||
| IMPORTANCE OF HL, SELF-MONITORING, AND LIFESTYLE CHANGES | 592 | ||
| SUMMARY | 593 | ||
| REFERENCES | 593 | ||
| Chapter 5. Management of High Blood Pressure in Children and Adolescents | 597 | ||
| DIAGNOSIS OF HYPERTENSION | 597 | ||
| OBESITY-RELATED HYPERTENSION | 599 | ||
| PHARMACOLOGIC TREATMENT OF CHILDHOOD HYPERTENSION | 601 | ||
| REFERENCES | 605 | ||
| Chapter 6. Treatment and Control of High Blood Pressure in Adults | 609 | ||
| CLASSIFICATION OF BP LEVELS AND STAGING OF HYPERTENSION IN ADULTS | 609 | ||
| DEFINITION AND RISK ASSESSMENT FOR TREATMENT PLANNING IN HYPERTENSION | 610 | ||
| LIFESTYLE MODIFICATIONS FOR THE PREVENTION AND CONTROL OF HIGH BP | 610 | ||
| SPECTRUM OF ORAL ANTIHYPERTENSIVE DRUGS AND CHOICE OF INITIAL THERAPY | 610 | ||
| THE ALGORITHM FOR HYPERTENSION TREATMENT AND FOLLOW-UP | 614 | ||
| STRATEGIES FOR DRUG SELECTION BEYOND THE INITIAL THERAPY | 616 | ||
| IMPORTANCE OF ADDRESSING ADVERSE DRUG EVENTS | 617 | ||
| ANTIHYPERTENSIVE THERAPY IN SPECIFIC POPULATIONS | 618 | ||
| EMERGING TREATMENT OF HYPERTENSION | 619 | ||
| SUMMARY | 620 | ||
| REFERENCES | 620 | ||
| Chapter 7. Hypertension in Special Populations: Chronic Kidney Disease, Organ Transplant Recipients, Pregnancy, Autonomic Dysfunction, Racial and Ethnic Populations | 623 | ||
| HYPERTENSION AND CHRONIC KIDNEY DISEASE | 623 | ||
| HYPERTENSION AND ORGAN TRANSPLANTATION | 625 | ||
| HYPERTENSION IN PREGNANCY | 626 | ||
| BARORECEPTOR DYSFUNCTION AND FAILURE AND HYPERTENSION | 630 | ||
| HYPERTENSION IN AFRICAN AMERICANS | 632 | ||
| REFERENCES | 635 | ||
| Chapter 8. Resistant Hypertension, Secondary Hypertension, and Hypertensive Crises: Diagnostic Evaluation and Treatment | 639 | ||
| SECONDARY HYPERTENSION | 639 | ||
| RESISTANT HYPERTENSION | 642 | ||
| HYPERTENSIVE CRISES | 650 | ||
| SUMMARY | 650 | ||
| REFERENCES | 651 | ||
| Chapter 9. Patient Self- Management Support: Novel Strategies in Hypertension and Heart Disease | 655 | ||
| WHAT IS SELF-MANAGEMENT OF HYPERTENSION AND CVD? | 655 | ||
| WHAT ARE THE GOALS OF EFFECTIVE SELF-MANAGEMENT? | 656 | ||
| HOW DOES SELF-MANAGEMENT FIT INTO THE LARGER CONTEXT OF THE HEALTH SYSTEM? | 657 | ||
| WHAT ARE THE EFFECTIVE COMPONENTS OF SELF-MANAGEMENT SUPPORT? | 657 | ||
| WHERE DOES SELF-MANAGEMENT SUPPORT OCCUR? | 658 | ||
| WHO DELIVERS SELF-MANAGEMENT SUPPORT? | 659 | ||
| WHAT IS THE EVIDENCE SUPPORTING SELF-MANAGEMENT INTERVENTIONS? | 660 | ||
| SUMMARY | 660 | ||
| REFERENCES | 661 | ||
| Chapter 10. The Role of Diets, Food, and Nutrients in the Prevention and Control of Hypertension and Prehypertension | 665 | ||
| DEFINITIONS AND CLASSIFICATIONS | 665 | ||
| DIET, FOODS, AND NUTRIENTS | 666 | ||
| ROLE OF VARIOUS DIETARY PATTERNS | 667 | ||
| ROLE OF MACRONUTRIENTS | 670 | ||
| ROLE OF MICRONUTRIENTS | 672 | ||
| ROLE OF CALORIES | 672 | ||
| ROLE OF DIETITIANS ON THE TREATMENT AND CARE TEAM | 672 | ||
| ROLE OF THE FOOD SYSTEM, INCLUDING FOOD MANUFACTURERS AND RESTAURANTS, IN ADDRESSING DIETARY SODIUM INTAKE | 673 | ||
| SUMMARY | 673 | ||
| REFERENCES | 673 | ||
| Chapter 11. Prevention, Diagnosis, and Treatment of Hypertensive Heart Disease | 675 | ||
| DEFINITION | 675 | ||
| PATHOPHYSIOLOGY | 675 | ||
| EPIDEMIOLOGY | 676 | ||
| DIAGNOSTIC EVALUATION | 676 | ||
| PREVENTION AND TREATMENT | 680 | ||
| SUMMARY | 685 | ||
| REFERENCES | 686 | ||
| Index | 693 |